Overview

Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole

Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
0
Participant gender:
Male
Summary
This study will examine if a single dose of Ciprofloxacin and Trimethoprim/Sulfamethoxazole are equivalent for prophylaxis immediately prior to prostate biopsy, when a patient has a suspected prostate cancer.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UmeƄ University
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Criteria
Inclusion Criteria:

- Indication for trans rectal prostate biopsy (Physicians discretion)

- Informed consent

Exclusion Criteria:

- Diabetes Mellitus

- Indwelling urinary catheter

- Prior urinary infection (last 6 months)

- Dipstick positive (Nitrites test)

- Allergy to Ciprofloxacin or Trimethoprim/Sulfamethoxazole

- Severe liver disease

- Concomittant use of Tizanidine

- Immunosuppression